![]() | |
Names | |
---|---|
IUPAC name
4-[[(4-Chlorophenyl)-(3-fluoro-6-oxocyclohexa-2,4-dien-1-ylidene)methyl]amino]butanoic acid
| |
Other names
Progabide acid; LS-187121; SL-75-102-00
| |
Identifiers | |
3D model (JSmol)
|
|
ChEBI | |
ChEMBL | |
ChemSpider | |
PubChem CID
|
|
UNII | |
| |
| |
Properties | |
C17H15ClFNO3 | |
Molar mass | 335.76 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
SL-75102, or progabide acid, is an active metabolite of progabide and an anticonvulsant GABA receptor agonist.[1][2]
References
[edit]- ^ Hamberger, C.; Barre, J.; Brandebourger, M.; Urien, S.; Taiclet, A.; Thenot, J. P.; Tillement, J. P. (April 1987). "Progabide and SL 75102 binding to plasma proteins and red blood cells in humans". Int J Clin Pharmacol Ther Toxicol. 25 (4): 178–84. PMID 3583466.
- ^ Kubová, H.; Haugvicová, R.; Mares, P. (1997). "Anticonvulsant effect of SL 75 102 in adult and immature rats". Physiol Res. 46 (1): 73–6. PMID 9728525.